Cardinal Health
Chemotherapy Gowns
This product consist of information only.
“Registered under Act 737” - GA18911793818
Poly-coated SMS chemotherapy gowns
Engineered to provide users with protection from the potential hazards associated with handling chemotherapy agents,
' Poly-coated material for durability and protection
•Lightweight, closed-back design, secure‹I with tles tar maximum comfort
•Low-llntlng material helps to provide a clean environment Long sleeves with knit cuffs provide added comfort
Poly-coated SMS chemotherapy gowns
Engineered to provide users with protection from the potential hazards associated with handling chemotherapy agents,
' Poly-coated material for durability and protection
•Lightweight, closed-back design, secure‹I with tles tar maximum comfort
•Low-llntlng material helps to provide a clean environment Long sleeves with knit cuffs provide added comfort
Overview
Reviews
Enquiry
The material used in these gowns was tested against the following 11 chemotherapy drugs per ASTM
F739-12 and no breakthrough was observed during test duration of 480 minutes based on average
standardized breakthrough time*:
• Carmustine • Cisplatin • Cyclophosphamide • Dacarbazine
• Doxorubicin Hydrochloride • Etoposide • Fluorouracil • Mitomycin C
• Paclitaxel • Thiotepa • Vincristine Sulfate
F739-12 and no breakthrough was observed during test duration of 480 minutes based on average
standardized breakthrough time*:
• Carmustine • Cisplatin • Cyclophosphamide • Dacarbazine
• Doxorubicin Hydrochloride • Etoposide • Fluorouracil • Mitomycin C
• Paclitaxel • Thiotepa • Vincristine Sulfate
| Cat. No. | Size/description | Qty. |
| 8200CG |
Universal, blue | 10/pk, 100/cs |
| 8201CG | X-large, blue | 10/pk, 100/cs |
Tell us what you think about this product, share your opinion with other people. Please make sure that your review focus on the product. Inappropriate reviews will not be posted.
Please login as customer to write a review.
Should you need more information on the product, kindly write your details to us.
